16th Annual Cardiometabolic Health Congress: Pushing Boundaries in Cardiometabolic Health - Challenges and Controversies

National Harbor, MD US
October 14, 2021 to October 17, 2021

The global epidemic of cardiometabolic disease demands the continual refinement of cardiometabolic care approaches and strategies. As the nation's premier event in cardiometabolic medicine, the 16th Annual Cardiometabolic Health Congress has been curated by the field's leading experts to deliver to you the latest evidence-based interventions to improve health outcomes and quality of life for the growing numbers of patients at increased cardiometabolic risk.

This year's Pushing Boundaries in Cardiometabolic Health: Challenges and Controversies will feature four days of new late-breaking research, FDA updates, clinical insights, and more all delivered through an actionable lens.

Target Audience

The Cardiometabolic Health Congress (CMHC) is designed for advanced level clinicians responsible for the prevention, diagnosis, and management of cardiometabolic risk including cardiologists, endocrinologists, diabetologists, lipidologists, pharmacists, primary care clinicians (PCPs), nurse practitioners (NPs), physician assistants (PAs), and other allied health professionals.

Learning Objectives

After completing this activity, the participant should be better able to:

  • DISCUSS the interrelationships among cardiometabolic risk factors and their impact on the development of cardiometabolic diseases, including diabetes, dyslipidemia, hypertension, obesity, kidney disease, and cardiovascular disease
  • INTERPRET the latest evidence and guidelines for the prevention, screening, and treatment of the complex patient with cardiometabolic risk or cardiometabolic disease
  • OUTLINE strategies aimed at timely screening and prevention of cardiometabolic disease, including assessment of risk factors and biomarkers, and lifestyle modifications
  • DEVELOP individualized treatment regimens for patients with cardiometabolic disease based on the efficacy and safety of current and new pharmacotherapies, patient comorbidities and preferences in order to optimize outcomes
  • SUMMARIZE recent evidence for emerging therapies in order to stay current with the most recent updates in the cardiometabolic field
  • RECOGNIZE the impacts of rare cardiometabolic diseases, including rare lipid, cardiovascular, diabetes, and obesity disorders, as well as potential implications for management
Course summary
Course opens: 
07/22/2021
Course expires: 
10/17/2021
Event starts: 
10/14/2021 - 12:00pm
Event ends: 
10/17/2021 - 11:45am
Cost:
$595.00
Rating: 
0
Gaylord National Harbor
201 Waterfront Street
National Harbor, MD 20745
United States

After an unexpected year filled with numerous changes, and a significant decrease in in-person interaction, the value and importance of building connections in-person is more evident than ever. Join CMHC just outside Washington, D.C. at the Gaylord National Resort in National Harbor to connect with like-minded peers and industry leaders.

JOINT ACCREDITATION STATEMENT

image image

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and CMHC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CONTINUING MEDICAL EDUCATION

The Postgraduate Institute for Medicine designates this live activity for a maximum of 17.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CONTINUING PHARMACY EDUCATION

Postgraduate Institute for Medicine designates this continuing education activity for 17.25 contact hour(s) (1.725 CEUs) of the Accreditation Council for Pharmacy Education.

This is an application-based activity. Universal Activity Number (UAN) TBD.

For Pharmacists: Upon completion of the online evaluation, your credit will be submitted to CPE Monitor within 4-6 weeks. Pharmacists have up to thirty (30) days from the live event to complete the evaluation and claim credit.

CONTINUING NURSING EDUCATION

The maximum number of hours awarded for this Continuing Nursing Education activity is 17.25 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate. To calculate hours a worksheet will be provided before the meeting. 

CONTINUING DIETICIAN EDUCATION
This program offers 17.25 CPEUs for dieticians.

ABIM MOC CERTIFICATION

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 17.25 MOC points in the American Board of Internal Medicine's (ABIM) maintenance of certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

DISCLOSURE OF CONFLICTS OF INTEREST

Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy.  PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Faculty
A full listing of faculty disclosures will be provided soon. 

Planners and Managers
The PIM planners and others have nothing to disclose. The CMHC planners and others have nothing to disclose.

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

HOW TO REQUEST CE CREDIT

Learners may earn up to a maximum of *21.25 AMA/ACPE/ABIM MOC/ANCC/CDR credit hours by attending all General Sessions (earn up to 17.25 hours) and CME Satellite Symposia (earn up to 4.0 hours). Satellite symposia CME information will be located in the conference guide.  

More information on how to claim credit will be provided soon. *Credit hours are subject to change.

FEE INFORMATION & REFUND/CANCELLATION POLICY

There is a registration fee for participating and receiving CME/CE credit for this educational activity. Registration information can be found here.

Price

Cost:
$595.00
Please login or register to take this course.